Related Experiment Videos
Lack of osteomalacia in chronic cholestatic liver disease
Insights
Patients with chronic cholestatic liver disease show bone changes more consistent with osteoporosis than osteomalacia. This study assessed bone health in these patients, finding reduced bone volume and mineralization rates.
Area of Science:
- Hepatology
- Endocrinology
- Bone Metabolism
Background:
- Chronic cholestatic liver disease (CCLD) can affect bone health.
- Distinguishing between osteomalacia and osteoporosis is crucial for patient management.
Purpose of the Study:
- To rigorously assess for osteomalacia in patients with CCLD using histologic definitions.
- To determine the primary type of metabolic bone disease in CCLD patients.
Main Methods:
- Histologic assessment of bone biopsies in 36 CCLD patients (33 primary biliary cirrhosis, 3 primary sclerosing cholangitis).
- Comparison of bone parameters (trabecular bone volume, osteoid volume, mineralization rates) with age- and sex-matched controls.
- Biochemical analysis of serum calcium, phosphorus, and 25-hydroxyvitamin D levels.
Main Results:
- Histologic findings indicated reduced bone volume, osteoid volume, osteoid surface, and mineralization appositional rate compared to controls.
- Significant decreases in osteoid seam width and prolonged mineralization lag time (in females) were observed.
- Biochemical markers did not support osteomalacia; 25-hydroxyvitamin D levels were not significantly different from controls.
Conclusions:
- Osteoporosis, not osteomalacia, appears to be the predominant metabolic bone disease in patients with chronic cholestatic liver disease.
- The study highlights the need for appropriate diagnosis and management of bone disease in this patient population.
Abstract:
Assessment of osteomalacia using rigorous histologic definition was carried out in 36 unselected patients with chronic cholestatic liver disease, 33 with primary biliary cirrhosis, and 3 with primary sclerosing cholangitis. Disease duration varied from 1 to 11 years. The mean values for total trabecular bone volume, osteoid volume, osteoid surface, and mineralization appositional rate were all decreased when compared to age-matched and sex-matched controls. There was a highly significant decrease in the mean osteoid seam width in both females (P = 0.001) and males (P = 0.02), and a significant prolongation of the mineralization lag time was found in females (P = 0.05), but failed to reach significance in males. These results excluded osteomalacia but were more indicative of osteoporosis. Biochemical evidence of osteomalacia was also absent, with serum calcium, serum phosphorus, and mean 25-hydroxyvitamin D levels not significantly different from control values, although there was a nonsignificant decrease in the mean value of 25-hydroxyvitamin D in patients with elevated serum bilirubin levels, and all patients with levels below 20 nmol/L had avoided sunlight exposure. The present results suggest that osteoporosis is the major type of metabolic bone disease in patients with chronic cholestatic liver disease.